South & Central America Home Infusion Therapy Market

The South & Central America home infusion therapy market is expected to grow from US$ 1,704.27 million in 2022 to US$ 2,587.96 million by 2028. It is estimated to grow at a CAGR of 7.2% from 2022 to 2028.

Addressing Unmet Needs of Patients Suffering from Oncological and Hematological Conditions is Driving

South & Central America Home Infusion Therapy Market

With a dramatic shift toward homecare during the COVID-19 pandemic, the pharmaceutical and medical industries are focusing on developing various types of drugs to be administered in homecare settings, through the combination of pumps and professional services. The past decades have witnessed a shift in the delivery of chemotherapy from the hospital inpatient setting to the hospital outpatient setting to the specialized community practice setting. Furthermore, with developments in healthcare, a homecare setting is likely to become the place of care for the infusion of chemotherapy drugs. Companies in the home infusion therapy market are working on expanding their business by focusing on the unmet needs of patients. Globally, ~380 marketed infusion drugs and an additional 160 drugs are currently in the Phase 3 of drug development; more than 70% of these have an oncology or hematology indication. Thus, with growing efforts to launch infusion therapies for providing treatment of cancer and IDA at home is likely to fuel the home infusion therapy market growth during the forecast period.

South & Central America Home Infusion Therapy Market Overview

The South & Central America home infusion therapy market is segmented into Brazil, Argentina, and the Rest of South & Central America. The high burden of cancer, the increase in the geriatric population that is at a greater risk of cancer, and efforts by government to reduce the incidences of these diseases are among the factors contributing to the growth of home infusion therapy market in South & Central America. Brazil is among the largest economy in South & Central America. It is the fifth largest country across the world by area and population and experiencing the fastest demographic aging worldwide. As per the Brazil Statistical Institute, people in Brazil aged 65 and above are expected to hold a 36% share of the total population of the country by 2050. The rising geriatric population in Brazil leads to an increased incidence of various health conditions such as cardiovascular diseases (CVD), which may increase morbidities and demand for home services in the healthcare system. Thus, the rising aging population and growing diabetes cases in Brazil are likely to fuel the adoption of infusion therapy at home, which will eventually drive the growth of the home infusion therapy market in the country during the forecast period.   

South & Central America Home Infusion Therapy Market Revenue and Forecast to 2028 (US$ Million)

South & Central America Home Infusion Therapy Strategic Insights

Strategic insights for the South & Central America Home Infusion Therapy provides data-driven analysis of the industry landscape, including current trends, key players, and regional nuances. These insights offer actionable recommendations, enabling readers to differentiate themselves from competitors by identifying untapped segments or developing unique value propositions. Leveraging data analytics, these insights help industry players anticipate the market shifts, whether investors, manufacturers, or other stakeholders. A future-oriented perspective is essential, helping stakeholders anticipate market shifts and position themselves for long-term success in this dynamic region. Ultimately, effective strategic insights empower readers to make informed decisions that drive profitability and achieve their business objectives within the market.

South & Central America Home Infusion Therapy Report Scope

South & Central America Home Infusion Therapy Regional Insights

The geographic scope of the South & Central America Home Infusion Therapy refers to the specific areas in which a business operates and competes. Understanding local distinctions, such as diverse consumer preferences (e.g., demand for specific plug types or battery backup durations), varying economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved areas or adapting their offerings to meet local demands. A clear market focus allows for more effective resource allocation, targeted marketing campaigns, and better positioning against local competitors, ultimately driving growth in those targeted areas.

South & Central America Home Infusion Therapy Market Segmentation

The South & Central America home infusion therapy market is segmented into product, application, route of administration and country.

Based on product, the home infusion therapy market is segmented into infusion pumps, intravenous sets, IV cannulas, and needleless connectors. The home infusion therapy market segment is sub segmented into insulin pumps, elastomeric pumps, syringe pumps, and others. The infusion pumps segment held the largest market share in 2022.  

Based on application, the home infusion therapy market is segmented into enteral nutrition, anti-infective, endocrinology, hydration therapy, chemotherapy, specialty pharmaceuticals, and others. The anti-infective segment held the largest share of the market in 2022.

Based on route of administration, the home infusion therapy market is segmented into intramuscular, subcutaneously, and epidural. The intramuscular segment held the largest share of the market in 2022. 

Based on country, the South & Central America home infusion therapy market is segmented into Brazil, Argentina, and the Rest of South & Central America. The Rest of South & Central America dominated the market in 2022.   

B. Braun Melsungen AG; Baxter International Inc; Nipro Corp; Becton Dickinson and Co; Fresenius Kabi AG; ICU Medical Inc; Terumo Corp are the leading companies operating in the South & Central America home infusion therapy market.